David Peterhoff

1.5k total citations
42 papers, 612 citations indexed

About

David Peterhoff is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, David Peterhoff has authored 42 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 18 papers in Molecular Biology and 11 papers in Virology. Recurrent topics in David Peterhoff's work include SARS-CoV-2 and COVID-19 Research (18 papers), HIV Research and Treatment (11 papers) and COVID-19 Clinical Research Studies (11 papers). David Peterhoff is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (18 papers), HIV Research and Treatment (11 papers) and COVID-19 Clinical Research Studies (11 papers). David Peterhoff collaborates with scholars based in Germany, Switzerland and United Kingdom. David Peterhoff's co-authors include Ralf Wagner, André Gessner, Miriam Breunig, Oscar P. Kuipers, Bernd Salzberger, Bárbara Schmidt, Jingjing Deng, Sven Panke, Steven Schmitt and Manuel Montalbán‐López and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

David Peterhoff

42 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Peterhoff Germany 14 314 281 86 73 62 42 612
Cuiling Zhang China 10 299 1.0× 171 0.6× 27 0.3× 167 2.3× 36 0.6× 25 741
Justin D. Hoopes United States 11 152 0.5× 208 0.7× 26 0.3× 183 2.5× 11 0.2× 11 625
Artur Szczepański Poland 12 170 0.5× 466 1.7× 51 0.6× 68 0.9× 7 0.1× 22 748
Lindsay G. A. McKay United States 9 121 0.4× 265 0.9× 38 0.4× 65 0.9× 8 0.1× 17 480
Xiaohui Wang China 17 292 0.9× 311 1.1× 26 0.3× 125 1.7× 6 0.1× 67 947
Л. Н. Черноусова Russia 18 298 0.9× 661 2.4× 47 0.5× 53 0.7× 19 0.3× 89 1.0k
Diana Flasher United States 12 201 0.6× 126 0.4× 20 0.2× 43 0.6× 36 0.6× 14 451
Dmitry Gryadunov Russia 18 330 1.1× 387 1.4× 114 1.3× 25 0.3× 6 0.1× 67 986
Vivek Murthy United States 10 275 0.9× 229 0.8× 25 0.3× 56 0.8× 5 0.1× 17 523
Daniel Sepúlveda‐Crespo Spain 16 232 0.7× 128 0.5× 23 0.3× 41 0.6× 6 0.1× 44 609

Countries citing papers authored by David Peterhoff

Since Specialization
Citations

This map shows the geographic impact of David Peterhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Peterhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Peterhoff more than expected).

Fields of papers citing papers by David Peterhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Peterhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Peterhoff. The network helps show where David Peterhoff may publish in the future.

Co-authorship network of co-authors of David Peterhoff

This figure shows the co-authorship network connecting the top 25 collaborators of David Peterhoff. A scholar is included among the top collaborators of David Peterhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Peterhoff. David Peterhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blaas, Stefan, Michael Pfeifer, Maximilian Malfertheiner, et al.. (2025). Hyper-reactivity of CD8+ T cells and high expression of IL-3 correlates with occurrence and severity of Long-COVID. Clinical Immunology. 277. 110502–110502. 2 indexed citations
2.
Civit, Laia, Benedikt Asbach, David Peterhoff, et al.. (2024). A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein. International Journal of Molecular Sciences. 25(9). 4642–4642. 3 indexed citations
3.
Werner, Maren Caroline Frogner, Heiko Siegmund, David Peterhoff, et al.. (2023). Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis. eLife. 12. 4 indexed citations
4.
Perdiguero, Beatriz, Carmen Gómez, David Peterhoff, et al.. (2023). Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein. Frontiers in Immunology. 14. 1270908–1270908. 1 indexed citations
5.
Weiß, Katharina, Sebastian Einhauser, David Peterhoff, et al.. (2023). Liposome-based high-throughput and point-of-care assays toward the quick, simple, and sensitive detection of neutralizing antibodies against SARS-CoV-2 in patient sera. Analytical and Bioanalytical Chemistry. 415(8). 1421–1435. 10 indexed citations
6.
Peterhoff, David, Sebastian Einhauser, Stephanie Beileke, et al.. (2023). Population-based study of the durability of humoral immunity after SARS-CoV-2 infection. Frontiers in Immunology. 14. 1242536–1242536. 1 indexed citations
7.
Peterhoff, David. (2023). New case of HIV cure: joined forces of haploidentical stem cells and HLA-mismatched cord blood. Signal Transduction and Targeted Therapy. 8(1). 241–241. 4 indexed citations
8.
Su, Jinpeng, Romina Bester, George Carnell, et al.. (2023). Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice. European Journal of Pharmaceutics and Biopharmaceutics. 192. 41–55. 4 indexed citations
9.
Vogel, Matthias, Annelie Plentz, Josef Köstler, et al.. (2022). Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals. iScience. 25(4). 104076–104076. 25 indexed citations
10.
Burkhardt, Ralph, et al.. (2022). Niedrige Inzidenz von SARS-CoV‑2-Infektionen bei Krankenhausmitarbeitern eines Maximalversorgers. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 117(8). 639–643. 1 indexed citations
11.
Köstler, Josef, Bernd Salzberger, Ralf Wagner, et al.. (2022). Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects. Infection. 50(6). 1475–1481. 11 indexed citations
12.
Peterhoff, David, Jan M. Sobczak, Mona O. Mohsen, et al.. (2021). Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery. Vaccines. 9(6). 642–642. 11 indexed citations
13.
Carnell, George, Kathrin Held, Guidenn Sulbarán, et al.. (2021). Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses. Vaccines. 9(7). 750–750. 9 indexed citations
14.
Peterhoff, David, Christian L. Johnson, Bárbara Schmidt, et al.. (2020). Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality. PLoS ONE. 15(12). e0243967–e0243967. 8 indexed citations
15.
Peterhoff, David, et al.. (2020). Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery. European Journal of Pharmaceutics and Biopharmaceutics. 156. 1–10. 9 indexed citations
16.
Schmitt, Steven, Manuel Montalbán‐López, David Peterhoff, et al.. (2019). Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale. Nature Chemical Biology. 15(5). 437–443. 91 indexed citations
17.
Peterhoff, David, et al.. (2019). Presentation of HIV-1 Envelope Trimers on the Surface of Silica Nanoparticles. Journal of Pharmaceutical Sciences. 109(1). 911–921. 18 indexed citations
18.
Perdiguero, Beatriz, Carmen Gómez, Juan García‐Arriaza, et al.. (2019). Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses. Frontiers in Immunology. 10. 2941–2941. 10 indexed citations
19.
20.
Peterhoff, David, et al.. (2012). Dimerization Determines Substrate Specificity of a Bacterial Prenyltransferase. ChemBioChem. 13(9). 1297–1303. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cuiling Zhang Breakdown of academic impact, for papers by Justin D. Hoopes Breakdown of academic impact, for papers by Artur Szczepański Breakdown of academic impact, for papers by Lindsay G. A. McKay Breakdown of academic impact, for papers by Xiaohui Wang Breakdown of academic impact, for papers by Л. Н. Черноусова Breakdown of academic impact, for papers by Diana Flasher Breakdown of academic impact, for papers by Dmitry Gryadunov Breakdown of academic impact, for papers by Vivek Murthy Breakdown of academic impact, for papers by Daniel Sepúlveda‐Crespo
Rankless by CCL
2026